Zobrazeno 1 - 5
of 5
pro vyhledávání: '"V. V. Mushtenko"'
Autor:
N. E. Kushlinskii, E. S. Gershtein, A. V. Kolpakov, S. D. Bezhanova, V. V. Mushtenko, E. A. Korotkova, D. Yu. Pushkar, V. V. Bazaev
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 48, Iss 2, Pp 78-83 (2020)
Background: Evaluation and search for new molecular markers of renal cell cancer, first of all, associated with angiogenic and invasive activity, continue to be highly relevant. In our previous publications, we have assessed the potential diagnostic
Externí odkaz:
https://doaj.org/article/6883655858c94f419fd49649dcb38a4b
Autor:
E. S. Gershtein, V. V. Mushtenko, E. A. Korotkova, S. D. Bezhanova, A. A. Morozov, A. A. Alferov, I. A. Kazantseva, N. E. Kushlinskii
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 45, Iss 2, Pp 94-101 (2017)
Background: The cause of late diagnosis of renal cancer lies in its durable, almost asymptomatic course. Due to the use of antiangiogenic therapies much progress has been made in its treatment in recent years. Yet, many questions concerning the diagn
Externí odkaz:
https://doaj.org/article/ed22f022192e4f83ae677c19cde0a701
Autor:
E. S. Gershtein, D Yu Pushkar, V. V. Mushtenko, S D Bezhanova, A. V. Kolpakov, N. E. Kushlinskii, E A Korotkova, V. V. Bazaev
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 48, Iss 2, Pp 78-83 (2020)
Background: Evaluation and search for new molecular markers of renal cell cancer, first of all, associated with angiogenic and invasive activity, continue to be highly relevant. In our previous publications, we have assessed the potential diagnostic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fe11ccf4d172dda5843eca6908f3684
https://www.almclinmed.ru/jour/article/view/1255
https://www.almclinmed.ru/jour/article/view/1255
Autor:
V. V. Mushtenko, E. S. Gershtein, D Yu Pushkar, Vsevolod Matveev, S D Bezhanova, Ivan Stilidi, N. E. Kushlinskii, A A Alferov
Publikováno v:
Bulletin of Experimental Biology and Medicine. 168:673-676
The study compared the levels of MMP-2,7,8,9, and TIMP-1 in blood serum of healthy people (N=97) and patients with primary renal cell carcinoma (N=93) to assess relevance of these markers to prognosis of overall survival of these patients, which were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d04d4fc6b38313413cf76dc49c64f0f0
https://doi.org/10.1007/s10517-020-04778-w
https://doi.org/10.1007/s10517-020-04778-w
Publikováno v:
Laboratornaya sluzhba. 6:6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::166c03102ff07586bb7e1280790c796d
https://doi.org/10.17116/labs2017616-13
https://doi.org/10.17116/labs2017616-13